Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On February 23, 2024, the Board of Directors of ADC Therapeutics SA (the "Company") approved the adoption of the ADC Therapeutics SA Annual Bonus Plan (the "Plan"). The Plan, a cash-based annual incentive plan, is intended to reward employees of the Company and its subsidiaries for their contributions to the success of the Company. Bonus payments will be based on the Company's achievement of corporate objectives. The named executive officers of the Company will be eligible to participate in the Plan, commencing with the 2024 annual bonus period.
The foregoing description of the Plan is not complete and is qualified in its entirety by the Plan, which is filed as Exhibit 10.1 hereto and incorporated by reference into this description.
Attachments
Disclaimer
ADC Therapeutics SA published this content on 29 February 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 29 February 2024 22:51:21 UTC.